MEBO International Debuts at Chile National Wound Foundation's First Wound Expo

MEBO International Debuts at Chile National Wound Foundation's First Wound Expo

From November 24 to 25, MEBO International was invited to participate in the first expo of the Chile National Wound Foundation (Fundación Instituto Nacional de Heridas), held in Santiago, Chile. The event brought together more than 1,700 healthcare professionals from across Latin America, alongside more than 40 international companies from China, the United States, Switzerland, Germany, and France, as well as Chilean enterprises.

During the opening ceremony, Isabel Aburto, President of the National Wound Foundation, stated that the expo's core mission is to provide a platform for exchange: by showcasing cutting-edge wound treatment technologies and innovative products from around the world, the event aims to share advanced experience, promote technological innovation, and raise wound care standards across Latin America.

MEBO International Debuts at Chile National Wound Foundation's First Wound Expo

At the expo, attendees were drawn to MEBO International's core product, Moist Exposed Burn Ointment, with detailed introductions to the product and the theory of regenerative medical technology. The event laid a solid foundation for the subsequent promotion and development of regenerative medical technology in Chile and the broader Latin American market.

MEBO International Debuts at Chile National Wound Foundation's First Wound Expo

Notably, during the event MEBO International delegation also met with Wang Hexing, President of the Chilean Chinese Business Association, holding in-depth discussions on regenerative medical technology and its application advantages.

By participating in this significant event, MEBO International not only presented the advantages of regenerative medical technology but also successfully built localized bridges of cooperation. Moving forward, MEBO International will continue collaborating with the global medical community to extend the benefits of regenerative medical technology to more patients worldwide.

This story was adapted from the original release published on mebo.education.